Personality disorder and drug use: A review

Drug and Alcohol Review

Volumn 16, Issue 3, 1997, Pages 235-250

  Seivewright, Nicholas ^a,c   Daly, Christopher ^b  

^a SHEFFIELD HEALTH AND SOCIAL CARE NHS FOUNDATION TRUST   (United Kingdom)

^b GREATER MANCHESTER MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^c Substance Misuse Service   (United Kingdom)

Author keywords

Drug misuse; Outcome; Personality disorder; Prevalence; Rating; Treatment

Indexed keywords

EID: 0031528859     PISSN: 09595236     EISSN: None     Source Type: Journal    
DOI: 10.1080/09595239800187421     Document Type: Review

References (110)

1. O'Hare PA, Newcombe R, Matthews A, Buning E, Drucker E. The reduction of drug-related harm. London: Routledge, 1992.
2. Cook CH. The Minnesota model in the management of drug and alcohol dependency: miracle, method or myth? Part I. The philosophy and the programme. Br J Addict 1988;83:625-34.
3. Craig RJ. Personality characteristics of heroin addicts: a review of the empirical literature with critique - Part II. Int J Addict 1979;14:607-26.
4. Penk WE, Woodward WA, Robinowitz R, Parr WC. An MMPI comparison of polydrug and heroin abusers. J Abnorm Psychol 1980;89:299-302.
5. Salmon R, Salmon S. The causes of heroin addiction - a review of the literature. Part I. Int J Addict 1977;12:679-96.
6. Reich JH, Vasile RG. Effect of personality disorders on the treatment outcome of Axis I conditions: an update. J Nerv Mental Dis 1993;181:475-83.
7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 2nd edn. Washington: American Psychiatric Association, 1968.
8. World Health Organization. The ICD-10 classification of mental and behavioural disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO, 1992.
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington: American Psychiatric Association, 1994.
10. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd edn. Washington: American Psychiatric Association, 1980.
11. Hathaway SR, McKinley JC. The Minnesota Multi-phasic personality inventory manual. Minnesota: University of Minnesota Press, 1951.
12. Klein DN. Depressive personality: reliability, validity and relation to dysthymia. J Abnorm Psychol 1990;99:412-21.
13. Zimmerman M. Diagnosing personality disorders. A review of issues and research methods. Arch Gen Psychiatry 1994;51:225-45.
14. Widiger TA, Frances A. Axis II personality disorders: diagnostic and treatment issues. Hosp Commun Psychiatry 1985;42:619-27.
15. Tyrer P, Casey P, Ferguson B. Personality disorder in perspective. Br J Psychiatry 1991;159:463-71.
16. Tyrer P. Measurement of abnormal personality: a review. J Roy Soc Med 1987;80:637-9.
17. Tyrer P, Seivewright H. Studies of outcome. In: Tyrer P, ed. Personality disorders: diagnosis, treatment and course. London: Wright, 1988.
18. Robins, L, Price R. Adult disorders predicted by childhood conduct problems: results from the NIMH Epidemiologic Catchment Area Project. Psychiatry 1991;54:116-32.
19. Moss HB, Tarter RE. Substance abuse, aggression and violence: what are the connections? Am J Addict 1993;2:149-60.
20. Hammersley R, Forsyth A, Lavelle T. The criminality of new drug users in Glasgow. Br J Addict 1990;85:1583-94.
21. Teichman M, Barnea Z, Ravav G. Personality and substance use among adolescents: a longitudinal study. Br J Addict 1989;84:181-90.
22. Soueif MI, Youssuf GS, Taha HS, et al. Use of psychoactive substances among male secondary school pupils in Egypt: a study on a nationwide representative sample. Drug Alcohol Depend 1990;26:63-79.
23. Paris J. Personality disorders: a biopsychosocial model. J Pers Dis 7:255-64.
24. Cloninger CR, Sigvardsson S, Bohman M. Predisposition to petty criminality in Swedish adoptees. II: cross-fostering analysis of gene-environment interaction. Arch Gen Psychiatry 1982;39:1242-53.
25. Torgesen S. Genetic factors in anxiety disorders. Arch Gen Psychiatry 1983;37:1272-77.
26. McGuffin P, Thapar A. The genetics of personality disorder. Br J Psychiatry 1992;160:12-23.
27. Coccaro EF, Siever LJ, Klar HM, et al. Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry 1989;46:587-99.
28. Cloninger CR. A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry 1987;44:579-88.
29. Siever LJ, Davis L. A psychobiological perspective on the personality disorders. Am J Psychiatry 1991;148:1647-58.
30. Loranger AW. Personality disorders examination (PDE) manual. Yonkers, NY: DV Communications, 1988.
31. Loranger AW, Susman VL, Oldham JM, Russakoff LM. The personality disorders examinations (PDE): a preliminary report. J Pers Dis 1987;1:1-13,
32. Spitzer RL, Williams JBW, Gibbon M. Structured clinical interview for DSM-III-R personality disorders (SCID-II). New York New York State Psychiatric Institute, Biometrics Research, 1987.
33. Stangl D, Pfohl B, Simmerman M, Bowers W, Carenthal C. Structured interview for DSM-III personality disorders. Arch Gen Psychiatry 1985;42:591-6.
34. Hyler SE, Rieder RO, Williams JBW, et al. The personality diagnostic questionnaire revised (PDQr R). New York New York State Psychiatric Institute, Biometrics Research, 1987.
35. Robins LN, Heizer JE, Croughan J, Ratcliff KS. National Institute of Mental Health diagnostic interview schedule: its history, characteristics and validity. Arch Gen Psychiatry 1981;38:382-9.
36. Millon T. Millon multiaxial inventory manual, 3rd edn. Minneapolis: National Computer Systems, 1983.
37. Millon T. Millon clinical multiaxial inventory manual supplement. Minneapolis: National Computer Systems, 1984.
38. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd edn, revised. Washington: American Psychiatric Association, 1987.
39. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 1978;35:773-82.
40. Spitzer RL, Endicott J, Robins E. Schedule for affective disorders and schizophrenia (SADS), 3rd edn. New York; New York State Psychiatric Institute, Biometrics Research, 1977.
41. Tyrer P, Alexander J. Classification of personality disorder. Br J Psychiatry 1979;135:163-7.
42. Mann AH, Jenkins R, Cutting JC, Cowen PJ. The development and use of a standardized assessment of abnormal personality. Psychol Med 1981;11:839-47.
43. Tyrer P, Alexander J, Ferguson B. Personality assessment schedule. In: Tyrer P, ed. Personality disorders: diagnosis, management and course. London: Wright, 1988:140-67.
44. Tyrer P, Alexander M, Cicchetti D, Cohen M, Remington M. Reliability of a schedule for rating personality disorders. Br J Psychiatry 1979;135:168-74.
45. Tyrer P, Strauss S, Cicchetti D. Temporal reliability of personality in psychiatric patients. Psychol Med 1983;13:393-8.
46. Perry JC. Problems and considerations in the valid assessment of personality disorders. Am J Psychiatry 1992;149:1645-53.
47. Weissman MM, Myers JK, Harding PS. Psychiatric disorder in a US urban community. Am J Psychiatry 1978;135:459-62.
48. Myers JK, Weissman MM, Tischler GL, et al. Six month prevalence of psychiatric disorders in three communities 1980-1982. Arch Gen Psychiatry 1984;41:959-67.
49. Robins LN, Heizer JE, Weissman MM, Orvaschel H, Gruenberg E, Burke JD, Regier DA. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984;41:949-58.
50. Casey P, Gall J. The relationship between neurosis and personality disorder. Br J Psychiatry 1983;142:404-8.
51. Kass F, Skodol AM, Charles E, et al. Scaled ratings of DSM-III personality disorders. Am J Psychiatry 1985;142:627-30.
52. Morey L. Personality disorders in DSM-III and DSM-III-R: convergence, coverage and internal consistency. Am J Psychiatry 1988;145:573-77.
53. Reich JH, Green AI. Effect of personality disorders on outcome of treatment. J Nerv Mental Dis 1991;179:74-82.
54. Tyrer P, Seivewright N, Ferguson B, et al. The Nottingham Study of Neurotic Disorder: relationship between personality status and symptoms. Psychol Med 1990;20:423-31.
55. Seivewright N. Relationship between life events and personality in psychiatric disorder. Stress Med 1987;3:163-8.
56. Rounsaville BJ, Weisman MM, Kleber H, Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry 1982;39:161-66.
57. Kosten TR, Rounsaville BJ, Kleber HD. DSM-III personality disorder in opiate addicts. Comp Psychiatry 1982;23:572-81.
58. Khantzian EJ, Treece C. DSM-III psychiatric diagnosis of narcotic addicts. Arch Gen Psychiatry 1985;42:1067-71.
59. Craig RJ. A psychometric study of the prevalence of DSM-III personality disorders among treated opiate addicts. Int J Addict 1988;23:115-24.
60. Clerici M, Carta I, Cazzullo CL. Substance abuse and psychopathology. A diagnostic screening of Italian narcotic addicts. Soc Psychiatry Psychiatric Epidemiol 1989;24:219-26.
61. Brooner RK, Schmidt CW, Felch LJ, Bigelow GE. Antisocial behaviour of intravenous drug abusers: implications for diagnosis of antisocial personality disorder. Am J Psychiatry 1992;149:482-7.
62. Gill K, Nolimal D, Crowley TJ. Antisocial personality disorder, HIV risk behaviour and retention in methadone maintenance therapy. Drug Alcohol Depend 1992;30:247-52.
63. DeJong CAJ, van den Brink W, Harteveld FM, van der Wielen EGM. Personality disorders in alcoholics and drug addicts. Comp Psychiatry 1993;34:87-94.
64. Darke S, Hall W, Swift W. Prevalence, symptoms and correlates of antisocial personality disorder among methadone maintenance clients. Drug Alcohol Depend 1994;34:253-7.
65. Rousar E, Brooner RK, Regier MW, Bigelow GE. Psychiatric distress in antisocial drug abusers: relation to other personality disorders. Drug Alcohol Depend 1994;34:149-54.
66. Vukov M, Baba-Milkic N, Lecic D, Mijalkovic S, Marinkovic J. Personality dimensions of opiate addicts. Acta Psychiatr Scand 1995;91:103-7.
67. Verheul R, van den Brink W, Hartgers C. Prevalence of personality disorders among alcoholics and drug addicts: an overview. Eur Addict Res 1995:1:166-77.
68. Malow RM, West JA, Williams JL, Sutker PB. Personality disorders classification and symptoms in cocaine and opioid addicts. J Consul Clin Psychol 1989;57:765-7.
69. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. J Am Med Assoc 1990;264:2511-8.
70. Zimmerman M, Coryell W. DSM-III personality disorder diagnoses in a non-patient sample: demographic correlates and comorbidiry. Arch Gen Psychiatry 1989;46:682-9.
71. Kranzler HR, Kadden RM, Burleson JA, Babor TF, Apter A, Rounsaville BJ. Validity of psychiatric diagnoses in patients with substance use disorders: is the interview more important than the interviewer? Comp Psychiatry 1995;36:278-8.
72. Bryant KJ, Rounsaville B, Spitzer RL, Williams JBW. Reliability of dual diagnosis: substance dependence and psychiatric disorders. J Nerv Mental Dis 1992;180:251-7.
73. Griffin ML, Weiss RD, Mirin SM, Wilson H, Bouchard-Voelk B. The use of the diagnostic interview schedule in drug-dependent patients. Am J Drug Alcohol Abuse 1987;13:281-91.
74. Dinwiddie SH, Reich T. Attribution of antisocial symptoms in coexistent antisocial personality disorder and substance abuse. Comp Psychiatry 1993;34:235-42.
75. Farrell M, Ward J, Mattick R, et al. Methadone maintenance treatment in opiate dependence: a review. Br Med J 1994;309:997-1001.
76. Kosten TA, Kosten TR, Rounsaville BJ. Personality disorders in opiate addicts show prognostic specificity. J Subst Abuse Treat ?;6:163-8.
77. McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients: the addiction severity index. J Nerv Mental Dis 1990;168:26-33.
78. Brooner RK, Bigelow GE, Strain E, Schmidt CW. Intravenous drug abusers with antisocial personality disorder: increased HIV risk behaviour. Drug Alcohol Depend 1990;26:39-44.
79. Brooner RK, Greenfield L, Schmidt C, Bigelow GE. Antisocial personality disorder and HIV infection among intravenous drug abusers. Am J Psychiatry 1993;150:53-8.
80. Darke S, Hall W, Swift W. Geographical differences in risk-taking among Sydney methadone maintenance patients: a comparison of inner city and outer south western methadone maintenance patients. Drug Alcohol Rev 1994;13:301-5.
81. Treece C, Nicholson B. DSM-III personality type and dose levels in methadone maitnenance patients. J Nerv Mental Dis 1980;168:621-8.
82. Leal J, Ziedonis D, Kosten T. Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence. Drug Alcohol Depend 1994;35:31-5.
83. Ravndal E, Vaglum P. Psychopathology and substance abuse as predictors of program completion in a therapeutic community for drug abusers: a prospective study. Acta Psychiat Scand 1991;83:217-22.
84. Ravndal E, Vaglum P. Changes in antisocial aggressiveness during treatment in a heirarchical therapeutic community. A prospective study of personality changes. Acta Psychiat Scand 1991;84:524-30.
85. Fals-Stewart W. Personality characteristics of substance abusers: an MCMI cluster typology of recreational drug users treated in therapeutic community and its relationship to length of stay and outcome. J Pers Assess 1992;59:515-27.
86. Kay SR, Kalathara M, Meinzer AE. Diagnostic and behavioural characteristics of psychiatric patients who abuse substances. Hosp Commun Psychiatry 1989;40:1062-9.
87. Toner BB, Gillies LA, Prendergast P, Cote FH, Browne C. Substance use disorders in a sample of Canadian patients with chronic mental illness. Hosp Commun Psychiatry 1992;43:251-4.
88. Dulit RA, Fyer MR, Haas GL, Sullivan T, Frances AJ. Substance use in borderline personality disorder. Am J Psychiatry 1990;147:1002-07.
89. Miller FT, Abrahams T, Dulit R, Fyer M. Substance abuse in borderline personality disorder. Am J Drug Alcohol Abuse 1993;19:491-7.
90. Sanguined VR, Samuel SE. Co-morbid substance abuse and recovery from acute psychiatric relapse. Hosp Commun Psychiatry 1993;44:1073-6.
91. Dinwiddie SH, Reich T, Cloninger CR. Psychiatric co-morbidity and suicidality among intravenous drug users. J Clin Psychiatry 1992;53:364-9.
92. Kernberg OD. Borderline conditions and pathological narcissism. New York: Jason Aronson, 1975.
93. Dahl G, Mersky DM. Clinical patterns in a behaviour modification unit. Can J Psychiatry 1981;26:460-3.
94. Novaco R. The cognitive regulation of anger and stress. In: Kendall P, Hollon S. eds. Cognitive-behavioural interventions: theory research and procedures. New York; Academic Press, 1979.
95. Parloff MB, Dies RR. Group psychotherapy outcome research 1966-1975. Int J Group Psychother 1977;27:281-319.
96. Appleby L, Joseph P. Management of personality disorder. Int Rev Psychiatry 1991;3:59-70.
97. Tyrer P, Seivewright N. Pharmacological treatment of personality disorders. Clin Neuropharmacol 1988;11:493-9.
98. Stein G. Drug treatment of the personality disorders. Br J Psychiatry 1992;161:167-84.
99. Gitlin MJ. Pharmacotherapy of personality disorders: conceptual framework and clinical strategies. J Clin Psychopharmacol 1993;13:343-53.
100. Norden MJ. Fluoxetine in borderline personality disorder: progress in neuropharmacology. Biol Psych 1989;13:885-93.
101. Markowitz PJ, Calabrese JR, Schulz SC, Meltzer HY. Fluoxetine in the treatment of borderline and schizotypal personality disorder. Am J Psych 1991;148:1064-67.
102. Kavoussi RJ, Liu J, Caccaro EF. An open trial of sertraline in personality disordered patients with impulsive aggression. J Clin Psychiatry 1994;55:137-41.
103. Amit Z, Smith R, Gill K. Serotonin uptake inhibitors: effects on motivated consummatory behaviours. J Clin Psychiatry 1991;52:55-60.
104. Sellers EM, Higgins GA, Tomkins DM, Romach MK, Toneatto T. Opportunities for treatment of psychoactive substance use disorders with serotenergic medications. J Clin Psychiatry 1991;52 (suppl):49-54.
105. Cowdrey RW, Gardner DL. Pharmacotherapy of borderline personality disorder alprazolam, carbamazepine, trifluperazeine and tranylcypromine. Arch Gen Psychiatry 1988;454:111-9.
106. Mos J, Olivier B. Pro-aggressive actions of benzodiazepines. In: Olivier B, Mos J, Brain PF, eds. Ethopharmacology of agonistic behaviour in animals and humans. Dordrecht: Martinus Nijhoff 1987;197-206.
107. Walker R. Substance abuse and B-duster disorders I: understanding the dual diagnosis patient. J Psychoact Drugs 1992;24:223-32.
108. Poison RG, Fleming PM, O'Shea JK. Fluoxetine in the treatment of amphetamine dependence. Hum Psychopharmacol 1993;8:55-8.
109. Pollack MH, Rosenbaum JF. Fluoxetine treatment of cocaine abuse in heroin addicts. J Clin Psychiatry 1991;52:31-3.
110. Gerra G, Marcato A, Caccavari R, et al. Clonidine and opiate receptor antagonists in the treatment of heroin addiction. J Subst Abuse Treat 1995;12:35-41.